BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Metipranolol

A beta-adrenergic antagonist effective for both beta-1 and beta-2 receptors. It is used as an antiarrhythmic, antihypertensive, and antiglaucoma agent.

218+ PubMed studies analyzed · 36 RCTs · Evidence Score: 48.5

Research Domains

Metipranolol has been studied across 17 research domains including 👁️ Vision & Eye, ❤️ Cardiovascular, 🔥 Metabolic, 🦴 Bone & Joint, 🧠 Focus & Attention. The primary research focus is 👁️ Vision & Eye with 35% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Metipranolol, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Epitestosterone
3 shared targets
dibekacin
2 shared targets
mezlocillin
2 shared targets
auricularum
3 shared targets
onapristone
2 shared targets
limonin
3 shared targets
enzalutamide
2 shared targets
Testolactone
2 shared targets
brilanestrant
2 shared targets
Clobetasol
2 shared targets
Loading evidence profile...

This evidence profile for Metipranolol is generated deterministically from 218 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.